In General Electric’s (GE) sale of its biopharmaceutical business to Danaher for US$21 billion, the Trilegal team supporting the multinational worked on the closing process while the COVID-19 lockdown in India was in place.
“This led to various challenges in logistics, co-ordination and execution,” Trilegal senior associate Aditi Jain told India Business Law Journal.
The completion of the sale of the business occurred at the end of March, and Trilegal advised GE on the matter. “We had to ensure that each task was completed in a timely manner, as any delays could lead to difficulties in the timely and scheduled closing of the transaction,” said Jain.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
